Topics

Companies Related to "Plasma Hydrogen Sulfide, Nitric Oxide and Stress Hyperglycemia in Acute Myocardial Infarction" [Most Relevant Company Matches] RSS

19:13 EST 9th December 2019 | BioPortfolio

Here are the most relevant search results for "Plasma Hydrogen Sulfide, Nitric Oxide and Stress Hyperglycemia in Acute Myocardial Infarction" found in our extensive corporate database of over 50,000 company records.

Showing "Plasma Hydrogen Sulfide Nitric Oxide Stress Hyperglycemia Acute" Companies 1–25 of 991

Extremely Relevant

Ikaria Holdings Inc.

Ikaria Holdings, Inc. is a biotherapeutics company whose acute care products and therapies address the significant unmet needs of critically ill patients. The company's lead product, INOmax(R) (nitric oxide) for inhalation, is the only FDA-approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns, and also is marketed in Canada, Europe, Latin America and Austral...


NicOx SA

NicOx aims to achieve profitability and growth through the research and development of nitric oxide therapeutics. NicOx begins its development process by taking well-known drugs and enhancing them with nitric oxide-releasing structures resulting in patentable new chemical entities.

GeNO LLC

GeNO LLC, founded in 2006, is a privately held, advanced development-stage technology company that is developing innovative nitric oxide (NO) generation and delivery platforms to enable the true potential of inhaled nitric oxide to be realized. The company is focused on applying the new technology to deliver inhaled nitric oxide to patients in a wide variety of settings, including ambulatory and ...


Medinox, Inc.

Medinox is a leader in anti-nitric oxide therapeutics and is developing a broad technology platform to address several unmet medical needs including hemodialysis, cardiopulmonary bypass surgery and septic shock. In addition to its nitric oxide technology, Medinox is also developing new and safer NSAID prodrugs for treating arthritic patients. For information about Medinox and its products, please ...

GeNOsys, Inc.

GeNOsys, Inc. (generated nitric oxide systems) is a medical research and development company specializing in pharmaceutical, biotechnical and medical gas generating systems. Nitric oxide gas will be one of the medical gases that will be generated along with various combinations of beneficial medical gases suitable for the control of human disease. Distribu...

Relevant

Arginox Pharmaceuticals, Inc

Arginox Pharmaceuticals is an emerging specialty biopharmaceutical company focusing on the discovery and development of breakthrough drugs for treating hospitalized patients. The company's initial area of research is directed at nitric oxide (NO), which has been shown in Nobel prize-winning research to play a role in a range of physiologic functions. Arginox is leading the way in developing drugs ...

Alexis Biochemical

ALEXIS, founded in 1993/94, is a worldwide operating producer and distributor of life science reagents. These reagents product lines have included: Apoptosis Cell Cycle & DNA Transactions Growth Factors, Cytokines & Chemokines Immunology & Cancer Research Neurochemicals Nitric Oxide & Oxidative Stress Signal Transduction & Cell Trafficking Over the years ALEXIS Corporation has developed a substant...

Alexis Corporation

ALEXIS Corporation, founded in 1993/94, is a worldwide operating producer and distributor of life science reagents. These reagents product lines have included: Apoptosis Cell Cycle & DNA Transactions Growth Factors, Cytokines & Chemokines Immunology & Cancer Research Neurochemicals Nitric Oxide & Oxidative Stress Signal Transduction & Cell Trafficking Over the years ALEXIS Corporation has develope...

NeurAxon, Inc.

NeurAxon, Inc. (www.neuraxon.com) discovers and develops next-generation pain therapeutics focused on its first-in-class selective inhibitors of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous system neuronal sensitization.

NeurAxon Inc.

NeurAxon, Inc. (www.neuraxon.com) discovers and develops next-generation pain therapeutics focused on its first-in-class selective inhibitors of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous system neuronal sensitization.

Medinox, Inc

Medinox, Inc. is a San Diego-based pharmaceutical company that is developing new small molecule drugs to treat a wide variety of unmet medical needs including sepsis, arthritis & inflammation, diabetes and sickle cell anemia. The Company's research and clinical development programs fall into two broad categories: 1) nitric oxide neutralizers, and 2) novel prodrugs.

Cellegy Pharmaceuticals

Cellegy Pharmaceuticals, Inc. is a specialty biopharmaceutical company engaged in the development and commercialization of prescription drugs including topical treatments for anal fissures and hemorrhoids and hormone replacement therapy for men and women. We recently expanded our research to include other potential products based on nitric oxide pharmacology through the acquisition of Vaxis Therap...

vasopharm GmbH

vasopharm is a pharmaceutical company dedicated to the discovery and development of novel therapeutics for the treatment of cerebro- and cardiovascular diseases and their consequences – indications with significant unmet clinical need. The company is focused on the development of therapeutics which steer the availability of biological nitric oxide (NO) over the entire NO signal cascade and its f...

Plasma Surgical

Founded in 2000, Plasma Surgical is a global company committed to advancing surgical technology that enhances the care and safety of patients during medical procedures. The company’s most revolutionary enhancement is the application of plasma surgery, where pure plasma is used to efficiently cut and coagulate tissue.

ASI Technology

ASI Technology is a small business specializing in the development of advanced patented technologies in support of DOD and commercial organizations. This corporation owns two patented plasma technologies: 1. Plasma Sound Reduction 2. Plasma Decontamination & Sterilization From 1999 to 2003 we pioneered plasma antenna technology developing this new technology for DOD and commercial applications...

Apieron, Inc.

Apieron, Inc. is a private, venture-backed medical device company based in Menlo Park, CA that was formed in early 2001 to develop a simple-to-use, non-invasive monitor for the measurement of exhaled nitric oxide (eNO) for the management of asthma. The Apieron biosensor technology platform utilizes a patented technology that allows for the highly sensitive detection of selected analytes like eNO. ...

HFactor

Founded in 2013, HFactor is the first functional water supercharged with the documented benefits of hydrogen – a powerful antioxidant and anti-inflammatory agent. HFactor is naturally infused with hydrogen to provide refreshing hydration plus therapeutic benefits for fitness, health and lifestyle recovery and wellness. It comes in a carry-anywhere pou...

Velico Medical, Inc.

Velico Medical, Inc. is a clinical-stage company developing proprietary technologies intended to make blood transfusions safer, more effective and less costly. The Company’s leading product-candidate is a technology to enable the spray drying of plasma to improve its availability and eliminate costs related to frozen plasma, the current standard of care. ...

Ikaria, Inc.

Ikaria, Inc. is a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to address the significant unmet needs of critically ill patients. The company's lead product is INOtherapy®, an all-inclusive offering of drug product, services and technologies. INOMAX® (nitric oxide) for inhalation, the drug included in the INOtherapy offering...

Ikaria Holdings, Inc.

Ikaria, Inc. is a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to address the significant unmet needs of critically ill patients. The company's lead product is INOtherapy®, an all-inclusive offering of drug product, services and technologies. INOMAX® (nitric oxide) for inhalation, the drug included in the INOtherapy offering...

Sankyo Kasei Co., Ltd.

Maeda Chemical Industry Co. merged with Asahi Chemical Industry Co. to establish Sankyo Kasei Co.Capital: ¥30 millionCapital increase: ¥50 million Sodium hydrosulfide plant completed (Akitsu Plant) Sodium sulfate plant completed (Mihara Plant) Crystal sodium sulfide plant No.1 completed (Akitsu Plant) Sodium hydrosulfide technical liquid plant (Kainan Work)Crystal sodium sulfide plant No.2, and ...

ADMA Biologics, Inc.

ADMA is a clinical stage biotechnology company which focuses its efforts on the development and commercialization of human plasma and plasma-derived therapeutics. ADMA’s mission is to develop and commercialize plasma-derived, human immune globulins targeted at niche patient populations with unmet medical needs. In addition, ADMA operates ADMA BioCente...

Consortium for Plasma Science LLC

The Consortium for Plasma Science, LLC, was formed in January 1997 to support the development of a universal approach to eradicate pathogens in whole blood plasma. The Consortium is cofunded by Alpha Therapeutic Corporation, a subsidiary of Mitsubishi Pharma Corporation; Aventis Behring; Baxter Healthcare Corporation; and Bayer Corporation.The Member companies have agreed on a focused strategy to ...

Antibe Therapeutics Inc.

Antibe Therapeutics Inc. originates, develops and out-licenses patent-protected new pharmaceuticals that are improved versions of existing drugs. These improvements are based on Nobel Prize-winning medical research highlighting the crucial role of gaseous mediators, which are chemical substances produced in the human body to regulate a range of fu...

PPTA Global

The Plasma Protein Therapeutics Association (PPTA) is the primary advocate for the world's leading source plasma collectors and producers of plasma-based and recombinant biological therapeutics. The medicines produced by PPTA members are used in treating life-threatening diseases and serious medical conditions including bleeding disorders, immune system deficiencies, alpha-1 antitrypsin deficienci...


More From BioPortfolio on "Plasma Hydrogen Sulfide, Nitric Oxide and Stress Hyperglycemia in Acute Myocardial Infarction"

Quick Search

Corporate Database Quicklinks